Expanded Access Policy
Ankasa Regenerative Therapeutics does not offer an expanded access program that allows patients to have access to the Company’s investigational products outside of clinical trials or prior to regulatory approval.
Questions regarding this policy should be sent via email to SAFETY@wnt3.com.
© 2021 Ankasa. All Rights Reserved